Gugnoni et al. found that CDH6 in papillary thyroid cancers (PTC) can be used as a pro-metastatic gene and serves as a biomarker in PTC cases with high invasive ability26. The gene discussed is CDH6; the disease is thyroid gland papillary carcinoma.